Exposure to styrene and mortality from nervous system diseases and mental disorders

American Journal of Epidemiology

Volumn 144, Issue 7, 1996, Pages 623-633

  Welp, Esther ^a,b   Kogevinas, Manolis ^a,c   Andersen, Aage ^d   Bellander, Tom ^e,f   Biocca, Marco ^g   Coggon, David ^h   Esteve, Jacques ^a   Gennaro, Valerio ⁱ   Kolstad, Henrik ^j   Lundberg, Ingvar ^e   Lynge, Elsebeth ^k   Partanen, Timo ^a,l   Spence, Alan ^m   Boffetta, Paolo ^a   Ferro, Gilles ^a   Saracci, Rodolfo ^a,n  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^g Ctro di Docum per la Salute   (Italy)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j AARHUS UNIVERSITY   (Denmark)

^k DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^l FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^m HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

ⁿ Istituto di Fisiologia Clinica   (Italy)

more..

Author keywords

central nervous system; cohort studies; mental disorders; mortality; occupational health; styrenes; suicide

Indexed keywords

SOLVENT; STYRENE;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PLASTIC INDUSTRY; RISK ASSESSMENT; SUICIDE;

EID: 10144243381     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008973     Document Type: Article

References (41)

1. IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994. IARC Monogr Eval Carcinog Risks Hum 1994;60: 233-320.
2. Collins DE, Richey FA Jr. Synthetic organic chemicals. In: Kent JA, ed. Riegel's handbook of industrial chemistry. 9th ed. New York: Van Nostrand Reinhold, 1992:800-62.
3. Astrand I. Uptake of solvents in blood and tissues of man. Scand J Work Environ Health 1975;1:199-218.
4. Berode M, Droz PO, Guillemin M. Human exposure to styrene. VI. Percutaneous absorption in human volunteers. Int Arch Occup Environ Health 1985;55:331-6.
5. Lewis RJ, Tatken RL. Registry of toxic effects of chemical substances. Vol 2. Cincinnati, OH: US Department of Health and Human Services, 1980.
6. Triebig G, Schaller KH, Valentin H. Investigations on neurotoxicity of chemical substances at the workplace. VII. Longitudinal study with determination of nerve conduction velocities in persons occupationally exposed to styrene. Int Arch Occup Environ Health 1985;56:239-47.
7. Cherry N, Gautrin D. Neurotoxic effects of styrene: further evidence. Br J Ind Med 1990;47:29-37.
8. Rosengren LE, Haglid KG. Long term neurotoxicity of styrene. A quantitative study of glial fibrillary acidic protein (GFA) and S-100. Br J Ind Med 1989;46:316-20.
9. Murata K, Araki S, Yokoyama K. Assessment of the peripheral, central, and autonomic nervous system function in styrene workers. Am J Ind Med 1991;20:775-84.
10. Matikainen E, Forsman-Gronholm L, Pfäffli P, et al. Nervous system effects of occupational exposure to styrene: a clinical and neurophysiological study. Environ Res 1993;61:84-92.
11. Triebig G, Lehrl S, Weltle D, et al. Clinical and neurobehavioural study of the acute and chronic neurotoxicity of styrene. Br J Ind Med 1989;46:799-804.
12. Arfini G, Mutti A, Vescovi P, et al. Impaired dopaminergic modulation of pituitary secretion in workers occupationally exposed to styrene: further evidence from PRL response to TRH stimulation. J Occup Med 1987;29:826-30.
13. Seppäläinen AM, Härkönen H. Neurophysiological findings among workers occupationally exposed to styrene. Scand J Work Environ Health 1979;3:140-6.
14. Härkönen H. Relationship of symptoms to occupational styrene exposure and to the findings of electroencephalographic and psychological examinations. Int Arch Occup Environ Health 1977;40:231-9.
15. Rosen I, Haeger-Aronsen B, Rehnstrom S, et al. Neurophysiological observations after chronic styrene exposure. Scand J Work Environ Health 1987;4(suppl 2):184-94.
16. Mutti A, Mazzucchi A, Rustichelli P, et al. Exposure-effect and exposure-response relationships between occupational exposure to styrene and neuropsychological functions. Am J Ind Med 1984;5:275-86.
17. Arlien-Soborg P. Solvent neurotoxicity. Boca Raton, FL: CRC Press, 1992.
18. Baker EL. Organic solvent neurotoxicity. Annu Rev Public Health 1988;9:223-32.
19. Hogstedt C. Has the Scandinavian solvent syndrome controversy been solved? Scand J Work Environ Health 1994;20: 59-64.
20. Kukull WA, Larson EB, Bowen JD, et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. Am J Epidemiol 1995;141:1059-71.
21. Bleecker ML. Invited commentary: Solvent exposure as a risk factor for Alzheimer's disease: a multiple insult hypothesis. Am J Epidemiol 1995;141:1072-4.
22. Coggon D, Osmond C, Pannett B, et al. Mortality of workers exposed to styrene in the manufacture of glass-reinforced plastics. Scand J Work Environ Health 1987;13:94-9.
23. Kogevinas M, Ferro G, Andersen A, et al. Cancer mortality in a historical cohort study of workers exposed to styrene. Scand J Work Environ Health 1994;20:249-59.
24. Kolstad H, Lynge E, Olsen J, et al. Incidence of lymphohematopoietic malignancies among styrene-exposed workers of the reinforced plastics industry. Scand J Work Environ Health 1994;20:272-8.
25. Kolstad HA, Juel K, Olsen J, et al. Exposure to styrene and chronic health effects: mortality and incidence of solid cancers in the Danish reinforced plastics industry. Occup Environ Med 1995;52:320-7.
26. Galassi C, Kogevinas M, Ferro G, et al. Biological monitoring of styrene in the reinforced plastics industry in Emilia Romagna, Italy. Int Arch Occup Environ Health 1993;65:89-95.
27. Jensen AA, Breum NO, Bacher J, et al. Occupational exposures to styrene in Denmark 1955-88. Am J Ind Med 1990; 17:593-606.
28. Götell P, Axelson O, Lindelöf B. Field studies on human styrene exposure. Work Environ Health 1972;9:76-83.
29. Coleman MP, Hermon C, Douglas A, et al. Cohort study analysis with a Fortran computer program. Int J Epidemiol 1986;15:134-7.
30. Pearce N, Checkoway H. A simple computer program for generating person-time data in cohort studies involving time-related factors. Am J Epidemiol 1987;125:1085-91.
31. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analyses. Epidemiology 1995;6:356-65.
32. Payne CD. The GLIM system: release 3.77. Oxford: Numerical Algorithms Group, 1985.
33. Allister C, Lush M, Oliver JS, et al. Status epilepticus caused by solvent abuse. Br Med J 1981;283:1156.
34. Arthur LJH, Curnock DA. Xylene-induced epilepsy following innocent glue sniffing. Br Med J 1982;284:1787.
35. Bernardini P, Scoppetta C. Exposure to solvents and tardy epilepsy: 2 clinical cases. Med Lav 1992;83:266-73.
36. Littorin ME, Fehling C, Attewell RG, et al. Focal epilepsy and exposure to organic solvents: a case-referent study. J Occup Med 1988;30:805-8
37. Byrne A, Kirby B, Zibin T, et al. Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry 1991;36: 735-8.
38. Jacobsen M, Baelum J, Bonde JP. Temporal epileptic seizures and occupational exposure to solvents. Occup Environ Med 1994;51:429-30.
39. Parker DL, Bender AP, Johnson RA, et al. Minnesota highway maintenance worker cohort mortality study: methods and non-cancer mortality. Am J Ind Med 1989;15:531-43.
40. Stewart PA, Schairer C, Blair A. Comparison of jobs, exposures, and mortality risks for short-term and long-term workers. J Occup Med 1990;32:703-8.
41. Arrighi HM, Hertz-Picciotto I. The evolving concept of the healthy worker survivor effect. Epidemiology 1994;5:189-96.